Influenza Pandemic
📧 Sign up to get email alerts when something new happens for Influenza Pandemic.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older [Phase 1, Phase 2]
Phase 1/2 clinical trial to evaluate safety and immunogenicity of a second-generation mRNA vaccine candidate targeting the H5 influenza hema…
-
EMA approval · 2009-10-02European Medicines Agency recommends authorisation of additional vaccine for influenza pandemic (H1N1) 2009
EMA recommends approving an additional influenza vaccine for the 2009 H1N1 pandemic, expanding vaccine options for this strain.
-
CLINICAL_TRIALS trial_result · 2007-03-13Clinical Trial Update: Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of two MF59C.1-adjuvanted influenza vaccines given in two doses three weeks apart in non-…